首页> 外文OA文献 >Analogs of human epidermal growth factor which partially inhibit the growth factor-dependent protein-tyrosine kinase activity of the epidermal growth factor receptor

【2h】

Analogs of human epidermal growth factor which partially inhibit the growth factor-dependent protein-tyrosine kinase activity of the epidermal growth factor receptor

机译：人表皮生长因子类似物，部分抑制表皮生长因子受体的生长因子依赖性蛋白酪氨酸激酶活性

页面导航

著录项
相似文献
相关主题

著录项

作者
Matsunami Risë K.; Campion Stephen R.; Niyogi Salil K.; Stevens Audrey;
展开▼
作者单位

展开▼
年度 1990
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Analogs of human epidermal growth factor which partially inhibit the growth factor‐dependent protein‐tyrosine kinase activity of the epidermal growth factor receptor [J] . Campion Stephen R., Matsunami Riseuml, K., FEBS Letters . 1990,第1期

机译：人类表皮生长因子类似物，部分抑制表皮生长因子受体的生长因子依赖性蛋白酪氨酸激酶活性
2. Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2 [J] . Tanaka Hidekazu, Hirata Michinari, Shinonome Satomi, Cancer science. . 2014,第8期

机译：表皮生长因子受体和人表皮生长因子受体2的口服可逆酪氨酸激酶抑制剂S-222611的临床前抗肿瘤活性
3. Preclinical antitumor activity of S‐222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2 [J] . Eugene P. Frenkel, Hidekazu Tanaka, Kanji Hojo, Cancer science. . 2014,第8期

机译：表皮生长因子受体和人类表皮生长因子受体2的口服可逆酪氨酸激酶抑制剂S-222611的临床前抗肿瘤活性
4. The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses Proliferation and Invasion of Human Oral Squamous Carcinoma Cells via p53 Independent and MMP, uPAR Dependent Mechanism [C] . EUN JU LEE, JIN HA WHANG, NAM KYEONG JEON, Meeting on Cell Signaling World: Signal Transduction Pathways as Therapeutic Targets . 2007

机译：表皮生长因子受体酪氨酸激酶抑制剂ZD1839（Iressa）通过独立于p53和MMP，uPAR依赖性机制抑制人口腔鳞状细胞癌细胞的增殖和侵袭
5. Mutational analysis of the E5 protein of human papillomavirus type 16 to analyze the role of interaction with the 16-kDa subunit of the vacuolar H(+)-ATPase in inhibiting activity of this complex and altering metabolism of the epidermal growth factor receptor. [D] . Adam, Jamie L. 2000

机译：人类乳头瘤病毒16型E5蛋白的突变分析，以分析与液泡H（+）-ATPase的16-kDa亚基相互作用在抑制该复合物活性和改变表皮生长因子受体代谢中的作用。
6. Preclinical antitumor activity of S-222611 an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2 [O] . Hidekazu Tanaka, Michinari Hirata, Satomi Shinonome, 2014

机译：表皮生长因子受体和人表皮生长因子受体2的口服可逆酪氨酸激酶抑制剂S-222611的临床前抗肿瘤活性
7. Antibodies to the ATP-binding site of the human epidermal growth factor (EGF) receptor as specific inhibitors of EGF-stimulated protein-tyrosine kinase activity [O] . William J. GULLICK, Julian DOWNWARD, J. Gordon FOULKES, 1986

机译：对人表皮生长因子（EGF）受体的ATP结合位点的抗体作为EGF刺激的蛋白酪氨酸激酶活性的特异性抑制剂

Analogs of human epidermal growth factor which partially inhibit the growth factor-dependent protein-tyrosine kinase activity of the epidermal growth factor receptor

著录项

相似文献

相关主题

期刊订阅